Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Association of AGTR1 with 18-month treatment outcome in late-life depression.

The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry - 1 Jul 2007

Kondo Douglas G, Speer Marcy C, Krishnan K Ranga, McQuoid Douglas R, Slifer Susan H, Pieper Carl F, Billups Ashley V, Steffens David C

Abstract excerpt

OBJECTIVE: Converging lines of evidence implicate vascular factors in late-life depression, and argue that late-life depression is a distinct entity among the mood disorders. The A1166C polymorphism in the angiotensin II receptor, vascular type 1 (AGTR1) gene has been associated with a range of vascular diseases. This study investigated the association of AGTR1 genotype on 18-month treatment outcome in late-life...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Age of Onset
Share to Algorithms

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cohort Studies

Share to Demography

Share to Depressive Disorder, Major

Share to Receptors, Angiotensin

Share to Receptors, G-Protein-Coupled

Share to Time Factors

Source

Identifiers

PMID: 17586781
DOI: 10.1097/JGP.0b013e31805470a4

Genes

AGTR1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Association of AGTR1 with 18-month treatment outcome in late-life depression.PMID 17586781Read ↗

SLC6A4 polymorphisms and age of onset in late-life depression on treatment outcomes with citalopram: a Sequenced Treatment Alternatives to Relieve Depression (STAR*D) report.Semantic proximity Read ↗

BDNF Val66Met genotype and 6-month remission rates in late-life depression.Semantic proximity Read ↗

11β-Hydroxylase (CYP11B1) gene variants and new-onset depression in later life.Semantic proximity Read ↗

BDNF Gene Polymorphism and Antidepressant Response in Han Chinese Patients with First-Episode Late-Life DepressionSemantic proximity Read ↗

The serotonin transporter gene locus in late-life major depressive disorder.Semantic proximity Read ↗

Brain-derived neurotrophic factor Val66Met polymorphism and 6-month antidepressant remission in depressed Caucasian patients.Semantic proximity Read ↗

Usefulness of mirtazapine and SSRIs in late-life depression. Post hoc analysis of the GUNDAM study.Semantic proximity Read ↗

Aneurysmal subarachnoid haemorrhage: Effect of CRHR1 genotype on mental health-related quality of life.Semantic proximity Read ↗

Genetic variants in the angiotensin I-converting-enzyme (ACE) and angiotensin II receptor (AT1) gene and clinical outcome in depression.Semantic proximity Read ↗

Race and depression: does race affect the diagnosis and treatment of late-life depression?Semantic proximity Read ↗

Beta Adrenoceptor Polymorphism and Clinical Response to Sertraline in Major Depressive Patients.Semantic proximity Read ↗

BDNF val66met polymorphism and depressive disorders in patients with acute coronary syndrome.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.